Wegovy’s weight-loss efficacy improves with higher dosage
HQ Team June 21, 2025: Novo Nordisk’s medicine Wegovy, at a higher dose, resulted in an average weight loss of 21% during trials.
Drugs
Health
Pharma
Drugs
Health
Pharma
Lilly, Sweden’s Camurus sign $870 million pact for incretin products
HQ Team June 4, 2025: Eli Lilly and Company and Sweden’s Camurus AB have signed a $870 million pact to develop incretin products.
Drugs
Health
Pharma
Regeneron to pay China’s Hansoh $80m upfront for weight-loss drug
HQ Team June 2, 2025: Regeneron Pharmaceuticals, Inc. will pay China’s Hansoh Pharmaceuticals Group Company Limited $80 million upfront to acquire rights for.
Drugs
Health
Research
In Hyderabad, India, 84% of IT workers have non-alcoholic fatty liver
HQ Team April 24, 2025: More than 84% of 345 information technology workers surveyed in an Indian city suffer from non-alcoholic fatty liver.
Drugs
Health
Medical
Bain Capital to buy Japan’s Mitsubishi Tanabe Pharma for $3.3 billion
Bain Capital, a US-based private investment company, will buy the pharmaceutical arm of the Mitsubishi Chemical Group Corp. for $3.3 billion, according to.
Uncategorized
New obesity, diabetic cures may emerge as scientists unveil brain atlas
Scientists have created an atlas of individual cells within the human brain region of the hypothalamus and identified new genes linked to obesity.
Drugs
Health
Medical
Novo’ Nordisk’s drug to cut kidney disease advance in diabetics gets nod
Novo Nordisk’s medicine has been approved by the US drug regulator for reducing the risk of kidney failure and death due to cardiovascular.
Drugs
Pharma
Research
New insights on GLP-1 drugs: Benefits and risks unveiled
HQ Team January 21, 2024: The popular diabetes drugs, glucagon-like peptide-1 (GLP-1) receptor agonists such as Ozempic, have gained immense popularity for their.
Drugs
Medical
Research
India’s Tata Group grants $57.8 million to build medical school in IT capital
Tata Group, a $165 billion Indian conglomerate, is set to build a medical school in the southern technology hub of Bengaluru by partnering.
Uncategorized
Novo Nordisk says its drug CargiSema cuts body weight by 22.7% in adults
Danish pharmaceutical company Novo Nordisk’s combination drug achieved a 22.7% weight-loss reduction compared to a dummy drug during end-stage trials, according to a.